Taipei, Taiwan

Yu-Chia Chuang

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yu-Chia Chuang in Peripheral Neuropathy Diagnosis and Treatment

Introduction

Yu-Chia Chuang is an accomplished inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics and treatment, particularly concerning peripheral neuropathy. His innovative work has the potential to improve the quality of life for many individuals suffering from this condition.

Latest Patents

Yu-Chia Chuang holds a patent for "Methods and kits for diagnosing and/or treating peripheral neuropathy." This patent discloses methods and kits designed to diagnose whether a subject is experiencing peripheral neuropathy pain. The method involves detecting the presence of advillin in a biological sample by forming an immune complex between advillin and a monoclonal antibody that specifically binds to it. Additionally, the patent outlines a method for treating subjects suffering from peripheral neuropathy pain.

Career Highlights

Yu-Chia Chuang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to engage in cutting-edge research and collaborate with other experts in the field.

Collaborations

One of his notable collaborators is Chih-Cheng Chen, who is also involved in research related to peripheral neuropathy. Their partnership exemplifies the collaborative spirit of innovation in the medical research community.

Conclusion

Yu-Chia Chuang's contributions to the diagnosis and treatment of peripheral neuropathy highlight the importance of innovation in healthcare. His work not only advances scientific knowledge but also offers hope for improved patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…